GlassScriptPhysician profile
David M Saltzberg
NPI 1356443360
$1,880.34
in general payments reported to CMS, 2019-2025
21 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $218 · 2021: $568 · 2022: $564 · 2024: $46.12 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $601.86 | 2019-2022 | |
| Janssen Biotech, INC. | $395.98 | 2019-2024 | Simponi Aria, Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $306.97 | 2019-2025 | Entyvio |
| Pfizer INC. | $81.24 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.26 | 2021-2022 | |
| Gilead Sciences, INC. | $40.56 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $39.75 | 2021-2022 | |
| Olympus America INC. | $36.21 | 2019 | |
| Celgene Corporation | $32.80 | 2021-2022 | |
| Genzyme Corporation | $29.57 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $29.29 | 2025 | Iqirvo |
| Boston Scientific Corporation | $29.24 | 2019-2020 | |
| Madrigal Pharmaceuticals | $28.71 | 2025 | Rezdiffra |
| Ardelyx, INC. | $26.59 | 2024 | Ibsrela |
| Acacia Pharma INC | $25.70 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $24.81 | 2021 | |
| Daiichi Sankyo INC. | $21.16 | 2019 | |
| Tersera Therapeutics LLC | $19.62 | 2021 | |
| Braintree Laboratories, INC. | $15.90 | 2025 | Suflave |
| Medtronic, INC. | $11.77 | 2021 | |
| Qol Medical, LLC | $8.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Saltzberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.